Amalgamated Bank Purchases 71 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Amalgamated Bank grew its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 0.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,347 shares of the biotechnology company’s stock after acquiring an additional 71 shares during the period. Amalgamated Bank’s holdings in Axon Enterprise were worth $4,516,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Avantax Advisory Services Inc. lifted its stake in Axon Enterprise by 0.8% in the 1st quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock valued at $1,659,000 after purchasing an additional 40 shares during the last quarter. Brookstone Capital Management increased its holdings in shares of Axon Enterprise by 5.1% during the 1st quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock worth $263,000 after acquiring an additional 41 shares during the last quarter. CWM LLC raised its stake in Axon Enterprise by 1.5% in the 2nd quarter. CWM LLC now owns 2,820 shares of the biotechnology company’s stock valued at $830,000 after acquiring an additional 43 shares during the period. Wealthspan Partners LLC lifted its holdings in Axon Enterprise by 4.9% during the 2nd quarter. Wealthspan Partners LLC now owns 965 shares of the biotechnology company’s stock valued at $284,000 after purchasing an additional 45 shares during the last quarter. Finally, Burns Matteson Capital Management LLC boosted its position in Axon Enterprise by 6.7% during the second quarter. Burns Matteson Capital Management LLC now owns 730 shares of the biotechnology company’s stock worth $215,000 after purchasing an additional 46 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently issued reports on AXON shares. Barclays raised their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Craig Hallum boosted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Jefferies Financial Group began coverage on Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $385.00 target price on the stock. Northland Securities boosted their price target on Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th. Finally, Robert W. Baird increased their price objective on Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 10th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus target price of $365.38.

Axon Enterprise Trading Up 0.9 %

AXON opened at $393.29 on Friday. The stock has a market capitalization of $29.72 billion, a price-to-earnings ratio of 115.00, a P/E/G ratio of 10.34 and a beta of 0.94. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a twelve month low of $189.12 and a twelve month high of $393.58. The company has a 50-day simple moving average of $348.04 and a 200 day simple moving average of $317.22.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. The company had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The firm’s quarterly revenue was up 34.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.80 EPS. Analysts predict that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction on Monday, September 16th. The stock was sold at an average price of $380.99, for a total value of $380,990.00. Following the transaction, the director now owns 27,259 shares in the company, valued at approximately $10,385,406.41. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the transaction, the chief executive officer now owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction on Monday, September 16th. The stock was sold at an average price of $380.99, for a total transaction of $380,990.00. Following the sale, the director now directly owns 27,259 shares in the company, valued at approximately $10,385,406.41. The disclosure for this sale can be found here. Insiders sold 317,981 shares of company stock worth $115,662,734 over the last three months. Insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.